Summary: Blood monocytes or intimal smooth muscle cells from normal aorta were incubated with low density lipoprotein (LDL) from patients with coronary atherosclerosis, or with LDL from diabetic patients, or with lipoprotein(a) (Lp(a)). In each case there was a 2-to 4-fold rise in the intracellular cholesteryl ester content. LDL from healthy subjects failed to induce intracellular lipid accumulation in these cells. LDL from patients with coronary atherosclerosis, LDL from diabetic patients, and Lp(a) form aggregates under cell culture conditions. The ability of these lipoproteins to increase the cholesteryl ester content of cultured cells is directly correlated to the degree of lipoprotein aggregation. When aggregates were removed from the lipoprotein preparations by filtration, the latter became less effective in promoting intracellular lipid accumulation. Incubation of cells with lipoprotein aggregates, isolated by gel filtration, induced a 3-to 5-fold elevation of the cellular cholesteryl ester content.
Introduction
. . . -« " u cations in vitro form aggregates under cell culture The accumulation of cholesteryl esters in intimal conditions (11) . The degree of aggregation of modified smooth muscle cells is one of the earliest manifesta-LDL is correlated with their ability to increase the tionsof atherosclerosis. Despite intensive investigative intracellular cholesterol ester content. Removal of work, the molecular mechanisms underlying lipid dep-these aggregates from preparations of modified LDL osition within the cells still remain unknown. Native resulted in a marked suppression of lipid accumula-LDL properly isolated from healthy subjects fails to tion in cultured cells. These findings demonstrate that induce intracellular lipid accumulation in cultured the ability of in vitro modified LDL to promote incells (1 -3) , while incubation of cells with LDL chem-tracellular lipid deposition depends largely on its agically modified by acetylation, methylation, glyc-gregation. Several types of modified LDL have been ation, oxidation, desialylation, or by malondialde-shown to occur in human blood. Thus Curtiss & hyde, glutaraldehyde or 4-hydroxynonenal treatment Witztum (12) demonstrated the presence of glycresults in deposition of lipid within the cells (1,3, ated LDL in the circulation of hyperglycaemic dia-4 -10). We recently reported that LDL after modifi-betic patients, and recently it was shown that LDL from atherosclerotic patients differs from LDL from healthy donors by a lower content of sialic acid (8, 9) . This desialylated lipoprotein species induces intracellular lipid accumulation in cultured aortic cells (13, 14) . Another circulating lipoprotein, which has been implicated in the deposition of lipids into cells (15 -18) is lipoprotein(a) (Lp(a)). This lipoprotein is similar to LDL but in addition to apolipoprotein B-100, it also contains the Lp(a) glycoprotein, apolipoprotein (a). The molecular mass of apolipoprotein(a) ranges from 350000 to 900000 depending on the genetic isoform (19) . In many epidemiological studies a positive correlation of high serum Lp(a) concentrations with coronary heart disease has been demonstrated (20) (21) (22) .
The present work was undertaken to study whether 1) LDL isolated from subjects suffering from coronary heart disease or diabetes show an increased tendency to form aggregates under cell culture conditions, 2) whether LDL aggregates or Lp(a) aggregates cause accumulation of cholesteryl esters into aortic intimal cells in culture, and 3) whether removal of these aggregates results in a decrease in intimal cholesteryl ester accumulation.
Materials and Methods

Preparation of lipoproteins
Low density lipoprotein (d = 1.019 -1.055 kg/1) was isolated by sequential ultracentrifugation (23) from: 1) combined plasma from 12 healthy subjects, 2) from 12 patients with coronary heart disease (angiographically documented stenosis of coronary arteries), and 3) from 12 non-insulin-dependent diabetic patients.
The clinical characteristics of the coronary heart disease patients and the healthy donors have been described (13, 14, 24) . None of the coronary heart disease patients or the healthy donors had diabetes mellitus. In the three groups the mean cholesterol concentrations were essentially similar, i.e. 5.12 + 0.33, 5.04 ± 0.26 and 4.76 ±0.13 mmol/1 for coronary heart disease patients, diabetic patients and healthy subjects, respectively. HDL-cholesterol concentrations in respective groups were 0.96 ± 0.10, 1.01 ± 0.08 and 1.14 ± 0.16 mmol/1. Plasma apolipoprotein B concentrations were 0.99 ± 0.07, 0.98 ± 0.09 and 0.88 ± 0.06 g/1, respectively for coronary heart disease and diabetic patients and for healthy subjects.
To prevent lipoprotein oxidation and proteolysis, butylated hydroxytoluene (final concentration 2 μηιοΙ/1) and phenylmethylsulphonyl fluoride (final concentration 1 mmol/1) were added. After recentrifugation at d = 1.055 kg/1, the LDL preparations were dialysed against phosphate-buffered saline, filtered through a 0.22 μιη polycarbonate filter and stored for a maximum of 7 days at + 4 °C. Immediately before use, the preparations were refilteted. The main characteristics of the LDL preparations obtained are summarized in table 1. The sialic acid content was determined by the method of Warren (25) . The extent of LDL glycation was evaluated from the fructosyl-lysine content, as determined by the method of KruseJarres et al. (26) using Boehringer Mannheim kits (Mannheim, Germany). The level of thiobarbituric acid reactive products in LDL and Lp(a) preparations was determined according to Yagi (27) .
Lipoprotein(a) was isolated by sequential ultracentrifugation, gel filtration on Sepharose 4B, and chromatography on Heparin Sepharose, as described previously (28, 29) .
Determination of the degree of lipoprotein aggregation and the size of aggregates
The degree of lipoprotein aggregation was evaluated by methods based on analysis of light transmission fluctuations in LDL and Lp(a) suspensions (30) . The aggregate size was determined by quasi-elastic laser scattering on an Autosizer 2 (Malvern Instrument, U. K.).
Cell culture
Subendothelial cells were isolated from grossly normal intima by dispersion of human aortic tissue with 1.5 g/1 collagenase, and cultured in growth medium containing Medium 199, fetal calf serum, volume fraction 0.1, 2 mmol/1 L-glutamine, and antibiotics (GIBCO Europe, Paisley) as described previously (31) . The cells were cultured at 37 °C in a humidified CO 2 -incubator (0.95 air/0.05 CO 2 ). The medium was changed every day. Starting from the 7th day in primary culture, cells were incubated for 6 h in medium containing LDL from healthy donors, or LDL from coronary heart disease patients or diabetic patients (protein 100 mg/1) and lipoprotein-deficient serum, volume fraction 0.1 (prepared by ultracentrifugation (23) from a healthy donor (d > 1.250 kg/1)). Medium and lipoprotein preparations were filtered (0.22 μιη pore size) immediately before adding to cell cultures. Human peripheral blood monocytes were isolated and incubated with lipoprotein preparations as described previously (24) . After incubation the cells were rinsed and cellular lipids determined, as described below.
Analytical methods
Protein was determined by the method of Lowry et al. (32) . Intracellular lipids were extracted with a w-hexane-isopropanol mixture (3 + 2, by vol.) as described elsewhere (33) . To determine the cholesterol ester content, the amount of free and total cholesterol was measured by the method of Siedel (34) using Boehringer Mannheim reagents (Mannheim, Germany). Lipids were extracted from lipoproteins with a chloroform-methanol mixture (2+1, by vol.) according to Bligh & Dyer (35) . Phospholipids and neutral lipids were separated by thin-layer chromatography and measured by scanning densitometry (31) . Lipoprotein(a) was quantitated with an immunoradiometric (IRMA)-method as described previously (36) .
Statistical analysis
The significance of differences between groups was evaluated by multiple t-test of one-way analysis of variance using a BMDP statistical program package (37) . The Bonferoni method was used to compare the study groups with the control group (38) . healthy subjects and atherosclerotic or diabetic patients are essentially similar. There was no significant difference in the content of thiobarbituric acid reactive substance between LDL preparations obtained from healthy subjects and patients. The sialic acid content in LDL of coronary heart disease patients was 3-fold lower than that measured in LDL of healthy subjects. In LDL of diabetic patients a high content of fructosyl-lysine was present due to enhanced glycation (tab. 1).
Results
Characterization of lipoprotein preparations
In Lp(a) isolated from coronary heart disease subjects the ratios between the major lipid classes were similar to those in LDL from healthy donors. The sialic acid content of Lp(a) was approximately 13-fold higher than that of LDL, while the thiobarbituric acid reactive substance content did not differ significantly from that of LDL.
Effect of lipoproteins on intracellular lipid accumulation
When intimal cells (cultured from grossly normal human aorta) were incubated in the presence of the different lipoprotein preparations, they accumulated varying quantities of cholesteryl esters (tab. 2).
After 6 h of incubation, LDL from healthy donors induced no significant increase in the intracellular cholesterol ester content. In contrast, LDL isolated from coronary heart disease patients significantly increased the cholesteryl ester content of the cultured cells (tab. 2). The intracellular cholesteryl ester content also increased after the cells had been incubated with LDL preparations from diabetic patients. This 6-h incubation of intimal cells with patient-LDL or LDL of healthy donors produced no significant increase in the intracellular content of free cholesterol (data not shown). Lipoprotein(a), at a concentration of 100 mg/1, induced a 3-fold increase in esterified cholesterol, but not in the free cholesterol content of the cells (tab. 2), compared with the concentration observed after incubation of the cells with LDL from healthy donors.
We also examined the effects of LDL and Lp(a) on the cholesteryl ester content of human peripheral blood monocytes. At a concentration of 50 mg/1, LDL isolated from coronary heart disease patients or diabetic patients, as well as Lp(a) promoted a 2 to 3-fold rise in intracellular cholesteryl ester in cultured monocytes (tab. 2), compared with that observed after incubation with LDL from healthy donors.
Lipoprotein aggregation under cell culture conditions After filtration, the average diameters of aggregates in filtered preparations of LDL from coronary heart disease patients were significantly reduced, compared with those in the initial preparations (tab. 4). When cells were incubated with these refiltered preparations, a much lower cholesteryl ester accumulation was observed, and when the LDL-preparations were passed through 0.1 μηι filters they completely lost their ability to induce intracellular lipid accumulation.
Lipoprotein aggregates were also removed by gel filtration. After passage through a Sepharose CL-2B column, isolated preparations of Lp(a), or patient-LDL, which initially caused intracellular lipid deposition in intimal cells, lost their ability to increase lipid accumulation (tab. 5).
As shown in Freshly filtered lipoprotein preparations were preincubated for 6 h at 37 °C. Aggregated and non-aggregated modified lipoprotein were separated by gel filtration on a Sepharose CL-2B column (1.6 χ 90 cm) at a flow rate of 1.5 ml/min. Fractions of aggregated and non-aggregated lipoproteins were pooled and examined for their ability to induce cholesteryl ester accumulation in cultured smooth muscle cells from grossly normal human aortic intima. The data are the means of 4 determinations ± SEM. * significant difference from control, p < 0.05. Control cells were incubated in Medium 199 with lipoprotern-deficient serum, volume fraction 0.1. Cholesteryl ester concentration in control smooth muscle cells was 29 ± 3 mg/g protein.
gates, induced a 4 -5-fold increase in intracellular cholesterol ester content. Similar results were obtained for cultured human peripheral blood monocytes (tab. 6). To find out whether the uptake of LDL aggregates was mediated by phagocytosis, we examined the influence of the phagocytosis inhibitor, cytochalasin B, on the cholesteryl ester accumulation in cultured cells caused by aggregates. This agent inhibited the increase of cholesteryl ester level both in smooth muscle cells and in monocytes (tab. 7). 
Discussion
The present study demonstrates the LDL isolated from patients with coronary heart disease or diabetes, as well as lipoprotein(a), induce accumulation of cholesteryl esters in cultured human aortic intimal cells and in peripheral blood monocytes. This is in contrast to LDL isolated from healthy subjects using the same techniques. We have previously shown that in vitro modified LDL undergoes aggregation, and that this aggregation of the modified LDL plays a crucial role in intracellular lipid accumulation (11) .
It was therefore of interest to study whether LDL isolated from patients might in vivo have been modified in such a way that they display a tendency to aggregate.
Here we provide evidence that LDL isolated from patients with coronary heart disease or diabetes mel- (40) . Our earlier findings show (11) that in vitro modified LDL spontaneously aggregate under the conditions of cell culture and that his aggregation is a necessary step in the process of cholesteryl ester accumulation within cultured human aortic smooth muscle cells. The present study indicates that, under these conditions, in vivo modified LDL also undergoes aggregation, and is able to increase the cholesteryl ester content of cultured aortic smooth muscle cells. In addition, cytochalasin B, an inhibitor of cellular phagocytosis, decreased the uptake and degradation of LDL aggregates. These findings strongly suggest that phagocytosis is the mechanism responsible for the uptake of LDL aggregates.
In earlier work it was demonstrated that oxidized and malondialdehyde-treated LDL show an increased tendency for aggregation (11) . Jürgens demonstrated that lysophosphatidylcholine can provoke aggregation of Lp(a) (41) . On the other hand, we have found that modified LDL and Lp(a) bind to native LDL (Tertov et al., unpublished data), an observation consistent with the findings of Ye et al. (42) . These data suggest that the aggregates may consist of both modified and native LDL.
In addition to LDL aggregates, "associates" between lipoproteins and various connective tissue components, such as proteoglycans (43, 44) , collagenaseresistent debris (45), heparin-fibronectin-denaturated collagen (46) , fibronectin (47) , and elastin (48) have been described. All these "associates" seem to be able to induce lipid accumulation in macrophages and smooth muscle cells. Recently, an association of LDL with mast cells and subsequent proteolytic modification of LDL were described, and it was shown that these mast cell-modified LDL are able to increase the cholesterol ester content of macrophages (49 -51). LDL-antibody complexes elicit the same effect (52) . Taken together, these data suggest that the formation of lipoprotein-aggregates favour the accumulation of cholesterol esters in human aortic intimal cells, and may play an important role in atherogenesis.
